NEW YORK, April 2 – Bioinformatics startup Softberry of Novosibirsk, Russia and White Plains, NY, said Monday it had licensed its human genome database to Biomax of Martinsried, Germany.

Valery Sagitov, president of Softberry, told GenomeWeb that the database contains predicted gene sequences as well as protein homologies.

To create the database, Softberry used its gene prediction programs to predict gene sequences in public databases and then ran those sequences against public protein databases in order to find homologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.